Accustem Sciences Inc. SEC filings ACUT

Accustem Sciences Inc. has 76 filings in SEC EDGAR's recent list, going back to Mar 12, 2021. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 26, 2025 (other events). The company's fiscal year ends on December 31.

Accustem Sciences Inc. SEC filings
Form Description Filed Period
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Apr 10, 2025 Apr 8, 2025
4 Insider transaction Apr 8, 2025 Mar 18, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2023 Dec 30, 2022
4 Insider transaction Dec 5, 2022 Dec 2, 2022
4 Insider transaction Nov 22, 2022 Nov 18, 2022
4 Insider transaction Aug 2, 2022 Aug 1, 2022
4 Insider transaction Jun 9, 2022 Jun 8, 2022
3 Initial insider ownership May 27, 2022 Dec 1, 2021
3 Initial insider ownership May 27, 2022 Mar 4, 2022
3 Initial insider ownership May 27, 2022 Dec 1, 2021
4 Insider transaction Apr 27, 2022 Apr 25, 2022
3 Initial insider ownership Jan 14, 2022 Dec 2, 2021
3 Initial insider ownership Dec 9, 2021 Dec 1, 2021
3 Initial insider ownership Dec 3, 2021 Dec 1, 2021

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACUT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1850767
Former names
AccuStem Sciences Ltd (until Jul 1, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.